![Monique Huser](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Monique Huser
Directeur/Membre du Conseil chez
Zikani Therapeutics, Inc.
Profil
Monique Schiersing Huser currently works at Zikani Therapeutics, Inc., as Director, Roche Ventures, as Senior Investment Director from 2020, Good Therapeutics, Inc., as Director, Lino Biotech AG, as Director, GlycoEra AG, as Director, and Bonum Therapeutics, Inc., as Director.
Ms. Huser also formerly worked at Opsona Therapeutics Ltd., as Director and Minoryx Therapeutics SL, as Director.
Ms. Huser received her Masters Business Admin degree in 2006 from the University of San Francisco and graduate degree in 1996 from the University of Zurich.
Postes actifs de Monique Huser
| Sociétés | Poste | Début |
|---|---|---|
Zikani Therapeutics, Inc.
 Zikani Therapeutics, Inc. Drugstore ChainsRetail Trade Focuses on the discovery and development of novel macrolide antibiotics for the treatment of life-threatening bacterial infections caused by drug resistant pathogens | Directeur/Membre du Conseil | - |
Roche Ventures
 Roche Ventures Investment ManagersFinance Roche Ventures invests in companies located in Switzerland and the United States. The firm focuses on pharmaceuticals, diagnostics and digital health. It participates in early stage capital transactions with an investment size of CHF 3 - 10 million. It acquires minority stakes and also makes follow-on financing. | Private Equity Investor | 01/03/2009 |
Lino Biotech AG
 Lino Biotech AG Miscellaneous Commercial ServicesCommercial Services Engages in research and development of biosensors & readers | Directeur/Membre du Conseil | - |
GlycoEra AG
 GlycoEra AG BiotechnologyHealth Technology Develops novel biologics to transform the treatment of autoimmune diseases | Directeur/Membre du Conseil | - |
Good Therapeutics, Inc.
 Good Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops bio-therapeutics and self-regulating drugs | Directeur/Membre du Conseil | - |
Bonum Therapeutics, Inc.
 Bonum Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops antibody-controlled cytokine based therapeutics designed to enhance the anti-tumor immune response | Directeur/Membre du Conseil | - |
Anciens postes connus de Monique Huser
| Sociétés | Poste | Fin |
|---|---|---|
Opsona Therapeutics Ltd.
 Opsona Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Provides immunology drug for treatment of inflammatory diseases | Directeur/Membre du Conseil | - |
Minoryx Therapeutics SL
 Minoryx Therapeutics SL BiotechnologyHealth Technology Develops pharmaceutical products | Directeur/Membre du Conseil | - |
Formation de Monique Huser
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
99
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
Zikani Therapeutics, Inc.
Zikani Therapeutics, Inc. Drugstore ChainsRetail Trade Focuses on the discovery and development of novel macrolide antibiotics for the treatment of life-threatening bacterial infections caused by drug resistant pathogens | Retail Trade |
University of San Francisco
 University of San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Roche Ventures
Roche Ventures Investment ManagersFinance Roche Ventures invests in companies located in Switzerland and the United States. The firm focuses on pharmaceuticals, diagnostics and digital health. It participates in early stage capital transactions with an investment size of CHF 3 - 10 million. It acquires minority stakes and also makes follow-on financing. | Finance |
University of Zurich
 University of Zurich Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Opsona Therapeutics Ltd.
Opsona Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Provides immunology drug for treatment of inflammatory diseases | Health Technology |
Minoryx Therapeutics SL
Minoryx Therapeutics SL BiotechnologyHealth Technology Develops pharmaceutical products | Health Technology |
Good Therapeutics, Inc.
Good Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops bio-therapeutics and self-regulating drugs | Health Technology |
Lino Biotech AG
Lino Biotech AG Miscellaneous Commercial ServicesCommercial Services Engages in research and development of biosensors & readers | Commercial Services |
GlycoEra AG
GlycoEra AG BiotechnologyHealth Technology Develops novel biologics to transform the treatment of autoimmune diseases | Health Technology |
Bonum Therapeutics, Inc.
Bonum Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops antibody-controlled cytokine based therapeutics designed to enhance the anti-tumor immune response | Commercial Services |
